Asia-Pacific RNAi for Therapeutic Market Analysis 2012-2017 and Forecast 2018-2023

ReportPage
Report ID
25659
Published Date
09-Mar
No of Report Page
94
Report Category
Pharmaceuticals and Healthcare
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details

    Snapshot
    RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all

    More...
  • Table Of Content

    Table of Content
    1 Industry Overview
    1.1 RNAi for Therapeutic Industry
    1.1.1 Overview
    1.1.2 Development of RNAi for Therapeutic
    1.2 Market Segment
    1.2.1 By Product Type
    1.2.2 By Application
    1.3 Asia-Pacific Overview
    2 Major Companies List
    2.1 Alnylam Pharmaceuticals (Company Profile, Products & Services, Sales Data etc.)
    2.2 Arrowhead (Company Pr

    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample